Phase IIb Study of IFN-K in Systemic Lupus Erythematosus

NCT02665364 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

185

Enrollment

INDUSTRY

Sponsor class

Stopped Reorganization proceedings of the sponsor

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: IFNα-Kinoid
OTHER: Placebo
OTHER: ISA 51 VG

Sponsor

Neovacs